Siak Leng Choi

Steady‐state pharmacokinetics and glucodynamics of the novel, long‐acting basal insulin <scp>LY2605541</scp> dosed once‐daily in patients with type 2 diabetes mellitus

Vikram Sinha, Daniel C. Howey, Siak Leng Choi et al. · Diabetes Obesity and Metabolism · 2013 · 61 citations

Medicine, Pharmacokinetics, Pharmacology +15

Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

Robert R. Henry, Sunder Mudaliar, Theodore P. Ciaraldi et al. · Diabetes Care · 2014 · 58 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Single‐dose pharmacokinetics and glucodynamics of the novel, long‐acting basal insulin LY2605541 in healthy subjects

Vikram Sinha, Siak Leng Choi, Danny Kwang Wei Soon et al. · The Journal of Clinical Pharmacology · 2014 · 49 citations

Medicine, Pharmacokinetics, Pharmacology +14

Reduced peripheral activity leading to hepato‐preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

Sunder Mudaliar, Robert R. Henry, Theodore P. Ciaraldi et al. · Diabetes Obesity and Metabolism · 2016 · 20 citations · Full text

Medicine, Endocrinology, Pharmacology +17